Discovery of Inhibitors of Aurora/PLK Targets as Anticancer Agents

Journal of Medicinal Chemistry
Baowen QiJianyou Shi

Abstract

Aurora and polo-like kinases control the G2/M phase in cell mitosis, which are both considered as crucial targets for cancer cell proliferations. Here, naphthalene-based Aurora/PLK coinhibitors as leading compounds were designed through in silico approach, and a total of 36 derivatives were synthesized. One candidate (AAPK-25) was selected under in vitro cell based high throughput screening with an IC50 value = 0.4 μM to human colon cancer cell HCT-116. A kinome scan assay showed that AAPK-25 was remarkably selective to both Aurora and PLK families. The relevant genome pathways were also depicted by microarray based gene expression analysis. Furthermore, validated from a set of in vitro and in vivo studies, AAPK-25 significantly inhibited the development of the colon cancer growth and prolonged the median survival time at the end of the administration (p < 0.05). To sum up, AAPK-25 has a great potential to be developed for a chemotherapeutic agent in clinical use.

References

Dec 1, 2000·Nature·B VogelsteinA J Levine
Mar 17, 2001·Chemistry & Biology·T Kodadek
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·E A Nigg
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqi Liu, Raymond L Erikson
Jan 23, 2004·Oncogene·Xiaoqi LiuRaymond L Erikson
Jun 3, 2004·Nature Reviews. Molecular Cell Biology·Francis A BarrErich A Nigg
Feb 16, 2005·Nature Biotechnology·Miles A FabianDavid J Lockhart
Mar 25, 2006·Nature Reviews. Cancer·Klaus Strebhardt, Axel Ullrich
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard D CarvajalGary K Schwartz
Feb 13, 2007·Current Biology : CB·Martin SteegmaierWolfgang J Rettig
Nov 8, 2007·Journal of Chemical Information and Modeling·Shashidhar N RaoJudith M LaLonde
Nov 17, 2007·Chemical Biology & Drug Design·Michael KotheYuan-Hua Ding
Jan 15, 2008·Regulatory Toxicology and Pharmacology : RTP·Kenneth T BogenCurtis J Omiecinski
Jun 19, 2008·Chemistry & Biology·Andrea G Cochran
Jul 11, 2008·Nature·Libor MacůrekRené H Medema
Mar 27, 2009·Journal of Medicinal Chemistry·John R Pollard, Michael Mortimore
Apr 10, 2009·European Journal of Pharmacology·Gum-Yong KangKwang Pyo Kim
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yan Degenhardt, Thomas Lampkin
Feb 24, 2010·Computer Methods and Programs in Biomedicine·Yong ZhangShaofei Xie
Apr 22, 2010·Journal of Chemical Information and Modeling·Jooyoung ChoiMark A Ragan
Jul 31, 2010·Nature Reviews. Drug Discovery·Klaus Strebhardt
Nov 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hyungshin Yim, Raymond L Erikson
Nov 26, 2010·Nature Reviews. Cancer·Susanne M A LensRené H Medema
Apr 22, 2011·Bioorganic & Medicinal Chemistry Letters·Jacques Yves GauthierW Cameron Black
Aug 2, 2011·Chemistry & Biology·Chandrasekhar V MiduturuNathanael S Gray
Oct 22, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark G ManfrediTodd B Sells
Feb 22, 2012·Investigational New Drugs·Madhu KollareddyMarian Hajduch
Apr 12, 2013·Cell Cycle·Mourad SanhajiJuping Yuan
May 27, 2014·European Journal of Medicinal Chemistry·Juan SunHai-Liang Zhu
Jun 24, 2014·Nature Reviews. Molecular Cell Biology·Sihem ZitouniMónica Bettencourt-Dias
Nov 5, 2014·Journal of Medicinal Chemistry·Jean-Christophe CarryCécile Combeau
Jan 30, 2015·World Journal of Gastroenterology : WJG·Li TaoYing-Jie Zhu
Mar 31, 2015·European Journal of Medicinal Chemistry·Wen-Wen QinLing Hui
Nov 26, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Renata FerrarottoFaye M Johnson

❮ Previous
Next ❯

Citations

Feb 13, 2021·Expert Opinion on Therapeutic Patents·Xue-Li Jing, Shi-Wu Chen
Mar 26, 2021·European Journal of Medicinal Chemistry·Zheng ZhangTingting Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.